A methylome-wide association study of major depression with out-of-sample case-control classification and trans-ancestry comparison
Shen, X.; Barbu, M.; Caramaschi, D.; Arathimos, R.; Czamara, D.; David, F.; Dearman, A.; Dilkes, E.; Herrera Rivero, M.; Huider, F.; Kühn, L.; Lu, K.-C.; Palviainen, T.; Schowe, A. M.; Shireby, G.; Weihs, A.; Wong, C.; Davyson, E.; Casey, H.; Adams, M.; Allgaier, A.-K.; Barber, M.; Burrage, J.; Caspi, A.; Costeira, R.; Dunn, E.; Feldmann, L.; Frank, J.; Freisleder, F. J.; Gadd, D. A.; Greimel, E.; Hannon, E.; Harris, S.; Homuth, G.; Howard, D.; Iurato, S.; Korhonen, T.; Lu, T.-P.; Martin, N.; Martins, J.; McDermott, E.; Meinert, S.; Navarro, P.; Ollikainen, M.; Pehl, V.; Piechaczek, C.; Scher
Show abstract
Major Depression (MD) is a leading cause of global disease burden, and both experimental and population-based studies suggest that differences in DNA methylation (DNAm) may be associated with the condition. However, previous DNAm studies have not so far been widely replicated, suggesting a need for larger meta-analysis studies. In the present study, the Psychiatric Genomics Consortium Major Depressive Disorder working group conducted a meta-analysis of methylome-wide association analysis (MWAS) for life-time MD across 18 studies of 24,754 European-ancestry participants (5,443 MD cases) and an East Asian sample (243 cases, 1846 controls). We identified fifteen CpG sites associated with lifetime MD with methylome-wide significance (p < 6.42x10-8). Top CpG effect sizes in European ancestries were positively correlated with those from an independent East Asian MWAS (r = 0.482 and p = 0.068 for significant CpG sites, r = 0.261 and p = 0.009 for the top 100 CpG sites). Methylation score (MS) created using the MWAS summary statistics was significantly associated with MD status in an out-of-sample classification analysis ({beta} = 0.122, p = 0.005, AUC = 0.53). MS was also associated with five inflammatory markers, with the strongest association found with Tumor Necrosis Factor Beta ({beta}=-0.154, p=1.5x10-5). Mendelian randomisation (MR) analysis demonstrated that 23 CpG sites were potentially causally associated with MD and six of those were replicated in an independent mQTL dataset (Walds ratio test, absolute {beta} ranged from 0.056 to 0.932, p ranged from 7x10-3 to 4.58x10-6). CpG sites located in the Major Histocompatibility complex (MHC) region showed the strongest evidence from MR analysis of being associated with MD. Our study provides evidence that variations in DNA methylation are associated with MD, and further evidence supporting involvement of the immune system. Larger sample sizes in diverse ancestries are likely to reveal replicable associations to improve mechanistic inferences with the potential to inform molecular target identification.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluating metabolome-wide causal effects on risk for psychiatric and neurodegenerative disorders 95%
- Chromatin remodeler developmental pluripotency associated factor 4 ( DPPA4 ) is a candidate gene for alcohol-induced developmental disorders 94%
- The effect of maternal BMI, smoking and alcohol on congenital heart diseases: a Mendelian randomization study 94%
Similar papers in this journal
- Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium 96%
- DNA methylation and general psychopathology in childhood: An epigenome-wide meta-analysis from the PACE consortium 96%
- Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions 96%
Similar papers in this journal
- Genetic insights into smoking behaviours in 10,558 men of African ancestry from continental Africa and the UK 96%
- Mendelian randomization study of spermine oxidase and cancer risk 96%
- A mesocorticolimbic dopamine gene network moderates the effect of early adversity on the risk for psychiatric and cardio-metabolic comorbidities 95%
Similar papers in this journal
- Combined prenatal Lactobacillus reuteri and ω-3 supplementation synergistically modulates DNA methylation in neonatal T helper cells 93%
- Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes. 92%
- DNAm scores for serum GDF15 and NT-proBNP levels associate with a range of traits affecting the body and brain 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.